Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The flaw with TLT

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Feb 02, 2022 12:14am

466 Views

Post# 34387929

RE:The flaw with TLT

I've been wondering how long before the FUD peddlers arrive on TLT board. You must have been sleeping under a rock not to know TLT's progress

Systemtogo wrote: The major flaw in it being used as a cancer treatment is that cancer is a metabolic disease of damaged mitochondria. Cancer feeds off of glucose and glutamine. Therefore, TLT's technology, like chemotherapy, doesn't get to the root of the problem and may even make patients worse by deflecting proper treatment. Thats not to say it doesn't have other therapeutic potential.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing